Daily Archives: April 18, 2024

Tech Firms Retreating From Office Market – The Real Deal

Posted: April 18, 2024 at 3:39 pm

Big tech firms have been solid business for office landlords across the country, but the end of a growth spurt in the sector means thats no longer the case.

Many of the top technology companies are downsizing or reevaluating their office needs across the country, the Wall Street Journal reported. Those firms reluctance to keep vast amounts of space is another hit to commercial owners.

Amazon, one of the largest office tenants in the entire country, is looking to reduce its office vacancies by passing on lease renewals, terminating some deals early and dropping underutilized floors.

Alphabets Google and Meta are also reconsidering their office needs. The former has listed office space in tech mecca Silicon Valley for sublease, while Mark Zuckerbergs company is leasing less space than it did at the onset of the pandemic, an acknowledgement that remote work is here to stay, as well as a cost-cutting measure being deployed by tech firms everywhere.

Meanwhile, in 30 cities with a high volume of technology tenants, office space up for sublease is at its highest levels in a decade, according to CBRE. The volume of new office space leased by tech companies in the fourth quarter was roughly half of the space leased in the same quarter in 2019.

The loss of tech tenants isnt only damaging to office landlords. It can also spell a dip in business for retail landlords in central business districts who rely on steady foot traffic to draw in business.

The vacancy rate of offices across the country rose to 19.8 percent in the first quarter, according to preliminary data from Moodys Analytics, representing a record for its tracker.

Holden Walter-Warner

Read this article:

Tech Firms Retreating From Office Market - The Real Deal

Posted in Big Tech | Comments Off on Tech Firms Retreating From Office Market – The Real Deal

Time for government to regulate big tech – ACS

Posted: at 3:38 pm

Reset Australia says Meta does not label all untrue content. Photo: Shutterstock

Digital advocacy group Reset Australia has sounded a clear alarm over voluntary big tech regulation and called on the federal government to step in after its complaint about Facebooks handling of misinformation was thrown out.

Reset Australia this week went public with its five-month long battle with Facebook parent company Meta and big tech representative mob Digital Industry Group Inc (DIGI) over the Australian Code of Practice on Disinformation and Misinformation.

Reset Australia has accused DIGI of a conflict of interest between its role in overseeing this code and in receiving funding from many of the companies subject to it.

It has urged the federal government to ditch its practice of using voluntary codes to oversee the tech sector and instead turn to big stick regulation.

In response, DIGI emphasised that the subcommittee handling complaints under the code is independent, that the industry group does not have a vote on it, and that voluntary industry codes designed by industry groups are common practice across a number of sectors.

The issue came to a head as a result of a statement made by Meta in its annual transparency report under the code, with the company saying that it has been applying a warning label to content found to be false by third-party fact-checking organisations.

Reset argued that this statement is untrue as Meta does not actually label all content that contains fact-checked falsehoods.

Metas policy involves the use of AI to find identical or near-identical versions of a post that has been found to be untrue by the independent fact-checkers.

Reset said that despite Meta claiming it is labelling all pieces of misinformation, many posts are slipping through the gap if they are merely worded slightly differently or even posted in a different colour.

Reset Australia produced 152 posts found to be repeating fact-checked falsehoods and reported these to Meta, but just 8 per cent of these posts were labelled.

In response to the letter, Meta agreed to provide further clarification on this process in this years annual report, but refused to make a public correction.

This led Reset to trigger the complaints process under the misinformation code, with an independent subcommittee meeting in March to discuss it.

This week the committee opted to reject Reset Australias complaint, finding that Meta had made a fair and reasonable offer to update its next report with additional information, but that this was rejected.

Reset said this is a mischaracterisation of what occurred.

We requested Meta provide further information so stakeholders could meaningfully verify the claims they made in their last transparency report, Reset Australia said in a statement.

We thanked Meta for their suggestion to add clarifying language in their next transparency report, but urged them to make a public correction. Meta refused to do that, and DIGI has endorsed their position.

Voluntary regulations

The decision reflects the weakness of the voluntary misinformation code, Reset Australia executive director Alice Dawkins said.

The decision today indicates that platforms can say what they like in their transparency reports and their source of independent audit does not have the capacity to run significant data testing of platforms claims, Dawkins said.

Reset Australia is now pushing for the federal government to step in and implement binding regulations and laws to oversee these big tech firms.

The Minister for Communications has said doing nothing is not an option, on misinformation. Well, were sounding a clear alarm that its time for government to do something, Dawkins said.

Big tech have carte blanche in Australia to make whatever decisions they like on our information environment, shroud those systems and processes in PR waffle and block critical scrutiny.

DIGI responds

DIGI managing director Sunita Bose in response said that it is common practice across a number of industries for these codes to be developed by industry associations.

As DIGI is an industry association for the technology sector, we have put strict firewalls in place to avoid conflicts of interest in our administration of the Australian Code of Practice on Disinformation and Misinformation, Bose said.

Bose said that the members of the complaints subcommittee are compensated by DIGI but are contractually independent, and that DIGI is the secretary of the subcommittee but cannot vote on its decisions.

In its decision, the independent subcommittee said that Reset Australia had produced no convincing evidence that Metas transparency report contained false statements, and that Meta has made information on its labelling and fact-checking processes available publicly.

Original post:

Time for government to regulate big tech - ACS

Posted in Big Tech | Comments Off on Time for government to regulate big tech – ACS

UK Markets Authority Warns of AI Market Capture by Big Tech – BankInfoSecurity.com

Posted: at 3:38 pm

Artificial Intelligence & Machine Learning , Next-Generation Technologies & Secure Development

The British antitrust authority warned Thursday that the market for foundational models in generative artificial intelligence is taking on "winner takes all" dynamics that could entrench a small number of providers.

See Also: 9 Best Practices for Artifact Management

U.K. Competition and Markets Authority head Sarah Cardell in a speech said the regulator won't repeat the hands-off approach that characterized its approach to digital markets over the past decade.

"Could we have responded faster to the competitive threats posed by large digital platforms, recognizing earlier that the tools we had would need adapting to address the unique challenges posed by this new breed of businesses? With the benefit of hindsight, I think the answer is almost certainly 'yes,'" she told a Washington, D.C. audience.

The same patterns of "incumbent firms leveraging their core market power to obstruct new entrants" is again present in the nascent generative AI market, Cardell said.

She pointed to a paper published that day by the CMA concluding that Google, Amazon, Microsoft, Meta and Apple - collectively dubbed the GAMMA firms - are presences up and down the foundational model value chain, raising the specter of greater levels of vertical integration.

Four firms with an outsize presence in offering compute or data resources - Amazon, Google, Meta and Microsoft - could restrict access to critical inputs. Incumbents for consumer or business facing markets could distort choices and restrict competition in foundational model deployment, the report states.

In addition to vertical integration, the regulator sounded a warning over a proliferation of partnerships and strategic investments, identifying an "interconnected web" of more than 90 firms involving GAMMA firms plus chip designer Nvidia

While partnerships could assist independent developers and increase competition, "we are also vigilant against the possibility that incumbent firms may try to use partnerships and investments to quash competitive threats, even where it is uncertain whether those threats will materialize," the report reads.

A Microsoft spokesperson said the company welcomes the "clarity and transparency provided by the report," and that the company is looking forward to engaging constructively with the UK CMA.

The report comes after some British lawmakers warned the competition regulator of potential risk arising from a small number of the largest tech companies influencing the policy developments in the country to use their products to power smaller models for market monopoly (see: UK Market Regulator Reviews Microsoft's Interest in OpenAI ).

Microsoft's close relationship with OpenAI faces similar scrutiny in the European Union. The European competition regulator is additionally investigating $16.3 million, multiyear partnership with Paris-based Mistral AI (see: EU to Analyze Partnership Between Microsoft and Mistral AI).

View post:

UK Markets Authority Warns of AI Market Capture by Big Tech - BankInfoSecurity.com

Posted in Big Tech | Comments Off on UK Markets Authority Warns of AI Market Capture by Big Tech – BankInfoSecurity.com

BrainsWay Expands Deep TMS Access in Israel Following Significant Increase in Reimbursement Rates – GlobeNewswire

Posted: at 3:38 pm

BURLINGTON, Mass. and JERUSALEM, April 17, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the further expansion of access to its Deep TMS treatment in Israel. BrainsWay has steadily increased its presence in the country with 11 recent system installations, and this momentum has been driven in part by a 45% increase in reimbursement rates. The Company expects to have additional Deep TMS systems installed in Israel by the end of 2024.

BrainsWay continues to make significant strides in expanding its international footprint, and it is extremely meaningful for us to be able to offer our life altering Deep TMS therapy to mental health patients across Israel, said Hadar Levy, Chief Executive Officer of BrainsWay. Following recent events in the country, serious mental health conditions are on the rise, and it is profoundly important to us that Deep TMS be made available to as many patients as possible, concluded Mr. Levy.

"This innovative technology represents a significant opportunity to treat numerous patients, including many who have not responded to medication, said Reut Filipowicz, BrainsWays Head of Business Development for the Israeli market. We are excited to bring Deep TMS to those suffering from mental health conditions who are truly in need of additional treatment solutions."

About BrainsWay BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with offices in Burlington, MA and Jerusalem, Israel, BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visitwww.brainsway.com.

Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words intends, may, will, plans, expects, anticipates, projects, predicts, estimates, aims, believes, hopes, potential or similar words. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In addition, historical results or conclusions from scientific research and clinical studies do not guarantee that future results would suggest similar conclusions or that historical results referred to herein would be interpreted similarly in light of additional research or otherwise. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: inadequacy of financial resources to meet future capital requirements; changes in technology and market requirements; delays or obstacles in launching and/or successfully completing planned studies and clinical trials; failure to obtain approvals by regulatory agencies on the Companys anticipated timeframe, or at all; inability to retain or attract key employees whose knowledge is essential to the development of Deep TMS products; unforeseen difficulties with Deep TMS products and processes, and/or inability to develop necessary enhancements; unexpected costs related to Deep TMS products; failure to obtain and maintain adequate protection of the Companys intellectual property, including intellectual property licensed to the Company; the potential for product liability; changes in legislation and applicable rules and regulations; unfavorable market perception and acceptance of Deep TMS technology; inadequate or delays in reimbursement from third-party payers, including insurance companies and Medicare; inability to commercialize Deep TMS, including internationally, by the Company or through third-party distributors; product development by competitors; inability to timely develop and introduce new technologies, products and applications, which could cause the actual results or performance of the Company to differ materially from those contemplated in such forward-looking statements.

Any forward-looking statement in this press release speaks only as of the date of this press release. The Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws. More detailed information about the risks and uncertainties affecting the Company is contained under the heading Risk Factors in the Companys filings with the U.S. Securities and Exchange Commission.

Contacts: BrainsWay: Ido Marom Chief Financial Officer Ido.Marom@BrainsWay.com

Investors: Brian Ritchie LifeSci Advisors britchie@lifesciadvisors.com

Media Contact: Chris Boyer Vice President, Marketing Chris.Boyer@BrainsWay.com

Read the original here:

BrainsWay Expands Deep TMS Access in Israel Following Significant Increase in Reimbursement Rates - GlobeNewswire

Posted in Tms | Comments Off on BrainsWay Expands Deep TMS Access in Israel Following Significant Increase in Reimbursement Rates – GlobeNewswire

New form of magnetic brain stimulation spells hope for patients with treatment-resistant depression – The Straits Times

Posted: at 3:37 pm

SINGAPORE In a first for South-east Asia, Singapore researchers are studying a personalised form of magnetic brain stimulation that can potentially help more people with treatment-resistant depression.

It involves mapping a persons brain using scans to locate a precise spot to target during the stimulation.

In Transcranial Magnetic Stimulation (TMS), which is already offered in Singapore, doctors stimulate a spot that is connected to a deep part of the brain that has been consistently implicated in depression.

Standard TMS, which is done without the brain-mapping, offers those diagnosed with treatment-resistant depression around a 30 per cent chance of getting well enough to not qualify for a depression diagnosis.

It delivers stimulation to the same spot of the brain for all patients.

As the layout and location of the brain networks are different for each person, the personalised version uses functional magnetic resonance imaging (fMRI) to pinpoint the exact spot unique to each patient, and stimulate it to treat their depression disorder as accurately as possible.

An artificial intelligence algorithm is used to clearly outline individual brain networks from the fMRI data, said Associate Professor Thomas Yeo, a brain scientist who is from the Centre for Sleep and Cognition at the Yong Loo Lin School Of Medicine at the National University of Singapore (NUS Medicine) and the co-principal investigator for the trials.

A high-precision robot arm is also used to target the stimulation.

The personalised TMS treatments are more intensive than the standard procedure 50 sessions are conducted over five days, instead of a minimum of 30 sessions over 30 days. Each personalised TMS session is 10 minutes long, while a standard TMS session can be 30 to 60 minutes long.

The Institute of Mental Health (IMH) is collaborating with NUS Medicine for two concurrent trials on personalised TMS, funded by separate parties. The trials started in March 2024 and will last for three years. The two trials will recruit a total of 90 patients, of whom 55 will undergo personalised TMS while the rest will be assigned to standard TMS.

Singapore is the first country in South-east Asia to conduct the clinical trials of personalised TMS, which is modelled after the personalised TMS approved for use in the US, known as the Stanford Accelerated Intelligent Neuromodulation Therapy protocol.

In the US (study), about 80 to 90 per cent of the patients get well with personalised TMS after one week. We will see whether it works in Asia, said Dr Tor Phern Chern, a senior consultant at the Mood and Anxiety department and Head of Neurostimulation Service at IMH, at a media briefing on April 12.

Dr Tor said that one day of 10 personalised TMS sessions is equivalent to six weeks of standard TMS, so it is like getting 7 months of TMS in five days. Whether this removes the need for individualisation is a question that one of the trials will attempt to answer.

Trial participants do not have to pay for the treatment. Temasek Foundation and the National Medical Research Council are funding the trials, each with a grant of $1 million.

Read more:

New form of magnetic brain stimulation spells hope for patients with treatment-resistant depression - The Straits Times

Posted in Tms | Comments Off on New form of magnetic brain stimulation spells hope for patients with treatment-resistant depression – The Straits Times

Choosing Regular Food to Extend Longevity – CounterPunch.org – CounterPunch

Posted: at 3:36 pm

Image by Brooke Cagle.

It is not often that a best-selling author and correspondent on consumer, food, medical, and health issues comes up with an idea for all Eaters that nobody has thought of before. Jean Carper, with sixty years of experience, has done just that with her brand-new book provocatively titled 100 Life or Death Foods: A Scientific Guide to Which Foods Prolong Life or Kill You Prematurely.

Based on scientific studies about the life-expectancy effect of different foods positive and negative (many cited in the books Appendix and available at the National Institutes of Health Library of Medicine). Carper writes: The evidence is stunningly clear that people who eat optimal diets can slow their aging process and add years to their lives.

Carper reports that researchers have found common legumes (beans, peas, soybeans), whole grains, and nuts, extend longevity, while refined grains (white bread), sugar-sweetened beverages, heavy salt use, and red and processed meats can shorten ones life.

Carpers book is instantly usable because she efficiently runs through specific foods. For example, studies give high life-extension marks to apples, bananas, beets, berries, cabbage, carrots, hot chili peppers, coffee, eggplant, fermented food (pickles and sauerkraut), garlic grapes and raisins, green leafy veggies, herbs and spices, kale, oats, olives and olive oil, brown rice, tea, tomatoes, vinegar, yogurt and whole grain cereals.

On the life-shortening side, she names alcoholic beverages, candy, diet sodas, cured meats (bacon, hot dogs), fried foods, ice cream, fruit juices (stripped of fiber and called high-calorie sugar water) ultra-processed foods, including those labeled with high amounts of sucrose, glucose, fructose, corn syrup, and refined sugary cereals that corporate hucksters advertise to youngsters.

In addition to specific foods, Carper explains why the Mediterranean Diet is so superior to the corporate Western Diet. She also praises the Dash Diet (similar to the Mediterranean Diet) which she reports as a famous blood pressure downer. She advocates getting your protein more from plants than from animals.

Much of the bad food cited in 100 Life or Death Foods is high on the list of the corporate marketeers who exploit taste and texture meaning sugar, salt, and fats to seduce children at a young age for a lifetime of ingesting junk food and junk drink. Their advertising is relentless, with heavy psychological manipulation. Fast food companies know from their own research the damage they have been doing to the health of their customers. That is why they fill their ads with lies and deceptions and have focused promotions on kiddy TV, over the decades.

The natural foods grown locally for generations have been mostly displaced by pesticide-heavy factory farms that fuel processed corporate diets.

This book is a guide for all eaters to work their way back to unprocessed natural foods, with organic-certified labels. These foods have another advantage they frequently come in at lower prices than steaks, chops, and highly processed foods, including those from fancy bakeries.

Carper recognizes, of course, that many factors influence life expectancy, such as genetics, exercise, lifestyles, smoking, pollution, alcohol abuse, and, of course, endemic poverty. Inadequate healthcare and health insurance also contribute to shortened life expectancies. However, food is something people can have personal control over without asking the permission of higher authorities.

Some people are in a position to grow their own vegetables and fruits and share the harvest with neighbors. Now you have what Carper calls a unique, up to date, one stop guide to more than 100 common foods, beverages and popular diets, revealing whether they prolong health and life or accelerate aging and death.

The guide works for all ages as well. It will show you that nutritious and delicious food prepared with all kinds of simple recipes can be healthy and tasty. (See,100 Life or Death Foods: A Scientific Guide to Which Foods Prolong Life or Kill You Prematurely, December 9, 2023).

Read more from the original source:

Choosing Regular Food to Extend Longevity - CounterPunch.org - CounterPunch

Posted in Life Extension | Comments Off on Choosing Regular Food to Extend Longevity – CounterPunch.org – CounterPunch